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Abstract
Context: Migraine is a major dilemma and problem which affects public health and results to reduced quality of life. This study
aimed to determine the prevalence of migraine in Iran.
Evidence Acquisition: A systematic search was conducted using Pub Med, Web of Science, Embase, Scopus, Ovid, Google Scholar, as
well as Iranian databases including: MagIran, IranMedex and Scientific Information Databank, from 2000 to November, 2015. The
Der-Simonian/Laird’s random-effects model, with a 95% confidence interval was employed to estimate the overall pooled prevalence.
Heterogeneity was investigated using subgroup analysis based on sample size and time of study.
Results: Thirty studies comprising 33,873 participants met the inclusion criteria for the analysis. The overall prevalence of migraine
in Iran was 14% (95% CI, 12% to 17%), respectively. The overall prevalence was (8%; 95% CI 6% to 11%) according to the international
classification of headache disorders (ICHD-1), (17%; 95% CI 13% to 21%) according to ICHD-2, and (18%; 95% CI 7% to 30%) according
to the other questionnaire for migraine screener (ID Migraine), respectively. Meta-regression demonstrated that the prevalence of
migraine increased by year of publication and decreased by sample size.
Conclusions: The prevalence of migraine in Iran, which was estimated as 14%, was similar or even higher than that reported world-
wide. Migraine can have impact on the economic productivity of any country; therefore it is necessary to educate people on the
early detection and the discovery of an effective treatment of migraine. More thorough review of further studies in this field is
recommended.
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1. Context
Headaches are one of the most common diseases
worldwide, and they occur in all age groups, from child-
hood to old age. Almost everyone experiences headache
in life (1). Primary disorders of headache include migraine
and tension-headaches (2). Migraine is a chronic neurovas-
cular disorder in the brain. Migraine headache is com-
monly throbbing and unilateral, and it is associated with
photophobia, phonophobia and/or nausea. It could be so
severe that it interferes with daily activity (3). People with
migraines suffer from pains and attacks which result from
the disease. Exposure to sun, stress, anxiety, sleep disor-
ders, multiple trips, eating habits, fatigue, smoking and
low levels of economic life are important risk factors as-
sociated with migraine (4). Migraine is a major dilemma
and problem of public health which leads to reduced qual-
ity of life. It also adversely affects the individual, family
and social activities (5). People between the ages of 10 to
40, who are considered as part of the economically active
workforce in every country, are more prone to migraine
attacks (6). Costs arising from the treatment of migraine
have great effect on the economy of any country, and due to
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the disability in the individual caused by the disease; there
is decrease in the production and productivity of the active
workforces of the society (5, 6). Studies have shown that
the prevalence rate of migraines in the world is between
10 and 18% (4). In Western countries, about 12% of the total
populations are affected by migraine, with females being
three times more prone to this disease than males (7). Ac-
cording to the global of burden disease (GBD) in 2013, mi-
graine is the sixth leading cause of disabilities in the world
(8). In recent years, several studies on the prevalence of
migraine in different population groups in Iran have been
conducted. The present study aimed to determine a gen-
eral estimate of the prevalence of migraine in Iran and also
to assess the general trend of the problem. This study is
the first systematic review and meta-analysis of migraine
prevalence in Iran. The results of this study may be helpful
in enlightening policy makers and authorities regarding
the real situation and necessity of adopting effective poli-
cies and programs for the purpose of reducing migraine in
Iran.
2. Evidence Acquisition
2.1. Data Source
Two authors carried out an independent international
databases search, including Pub Med, Web of Science (ISI),
Embase, Scopus, Ovid, Google Scholar, while the Iranian
databases search included MagIran, IranMedex and Sci-
entific Information Databank (SID). This search was con-
ducted up to November, 2015. Databases were searched us-
ing the Mesh terms like “Prevalence”, “Migraine” and re-
lated terms of studies published in Persian and English lan-
guages. References of articles were also checked for any rel-
evant articles. Figure 1 shows the literature search in accor-
dance with the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) (9).
2.2. Study Selection
Inclusion criteria were: Studies which reported rate of
migraine prevalence among an Iranian-based population,
studies which utilized the International system of classi-
fication of headache disorder (ICHD) criteria or screening
tools for the prevalence of migraine, case-control studies
or cohort studies. The exclusion criteria were: unknown
sample origins, unclear results and methods, use of case
reports and case series design, studies in which the treat-
ment was intended, studies which reported migraine in-
cidence among non-Iranian nationality, meta-analysis, re-
views, meeting abstract or editorial comments, and stud-
ies having duplicate data.
Articles were independently screened by two authors
for relevance, and conflicts were resolved by discussion
and a third author.
2.3. Data Extraction
Variables extracted for each study included: First au-
thor’s name, publication year, location of studies, age, the
gender of the participants, sample size, number of cases,
screening method, STROBE quality and diagnostic criteria.
Assessment of the quality of the studies was done using
strengthening the reporting of observational studies in
epidemiology (STROBE) checklist (10). The base checklists
of STROBE for the studies were classified in three categories
which included high, intermediate and low quality. Seven
items from the recommended checklist of STROBE were se-
lected and used for assessing the quality of studies. These
items included: present the key elements of the study de-
sign, clearly define the outcome of migraine, give the eli-
gibility criteria, explain how the study sample was arrived
at, describe the setting, locations, and relevant dates, give
sources of data and details of methods of assessment, and
describe all statistical methods. The studies were classified
as high quality if all items were achieved, as intermediate
quality if they did not achieve one criterion, and as low
quality if they did not achieve more than one criterion.
2.4. Statistical Analysis
A pooled estimated prevalence of migraine was gen-
erated using Der-Simonian and Laird’s random-effects
model. The reported effective estimate with 95% con-
fidence interval (CI) variance for the studies was calcu-
lated using the Binomial distribution formula. Statistical
heterogeneity was assessed among the studies using Chi-
square-based Q test and I2 (11).
All statistical significances were at P-values less than
0.05. The sources of heterogeneity were obtained using
meta-regression which was analyzed on the prior knowl-
edge of effective factors, such as sample size and publica-
tion year. Also, subgroup analysis by sample size, diagnos-
tic criteria, groups, geographical region, and quality of the
studies was done to obtain the source of heterogeneity. A
sensitivity analysis was performed to determine the effect
of each study on the prevalence of migraine by sequen-
tially omitting each data set. Egger’s test and funnel plot
was used to assess publication bias (12). All data were an-
alyzed using STATA Ver.12 (Stata Corp, College Station, TX,
USA).
3. Results
All databases (English and Persian) were searched from
2000 to 2015 (11 years), using the search keywords. The
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Figure 1. Flowchart of Search and Studies Selection
following search strategy” migraine” OR “headache” AND
“prevalence” AND “Iran” were used. Two authors indepen-
dently assessed the abstract and full-text studies and se-
lected the studies using the inclusion and exclusion crite-
ria. Finally, 30 articles which comprised 33,873 participants
were included in this systematic review and meta-analysis
study (13-42). The results of literature searches are shown
in Figure 1 and Table 1. The pooled prevalence of migraine,
using the random-effects model in Iran, was 14% (95% CI
12% to17%), and this is considered as significant (P < 0.05)
(Figure 2). The results of Q Cochran test = 2603.99 and I2 =
98.9%, d.f = 29; (P <0.0000) showed the prevalence of mi-
graine as being strongly heterogeneous among 30 studies.
The minimum prevalence of migraine was 2% (95% CI 1%
to 2%) according to Ayatollahi (2006) (22) in Shiraz, a town
province, respectively, and the maximum prevalence of mi-
graine was (46%, 95% CI 39% to 53%) according to Tavasoli
(2013) (38) in Tabriz town, respectively. The prevalence of
migraine based on provinces in Iran is shown in Figure 3.
Meta-regression showed that the prevalence of migraine
increased by publication year and decreased by sample
size (Table 2 and Figure 4). Based on analysis of the quality
of studies which included meta-analysis, according to the
STROB check list, it was observed that fifteen studies (50%)
were of high quality, eight studies (26.6%) were of interme-
diate quality, and seven studies (23.4%) were of low quality.
The results of the subgroup analysis showed the preva-
lence of migraine in Iran based sample size, diagnostic cri-
teria, groups and geographical region, was performed.
The pooled prevalence was based on sample size as
shown in Figure 5. The pooled prevalence was based on di-
agnostic criteria as shown in Figure 6. The pooled preva-
lence was based on groups of participants as shown in Fig-
ure 7. The pooled prevalence was based on geographical
region as shown in Figure 8. The pooled prevalence was
based on quality of studies as shown in Figure 9.
For robustness of result, sensitivity analysis was per-
formed by eliminating each study. There was no signifi-
cant change in the overall prevalence (Figure 10). Figure 11
shows the analyses of the publication bias of studies in re-
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Table 1. Characteristics of All Eligible Studies
Author Year Cities Sample Size Diagnostic Criteria Participants Type of Study
Yousefi 1999 Zanjan 554 ICHD-1 Students Cross-sectional
Naderi 2000 Kerman, Isfahan, Sharekord 700 ICHD-2 Students Cross-sectional
Ayatollahi 2002 Shiraz 1868 ICHD-1 Population-based Cross-sectional
Mirzaee 2004 Sharehkord 550 ICHD-1 Students Cross-sectional
Ghayeghran 2004 Rasht 1965 ICHD-1 Students Cross-sectional
Moaiedi 2004 Bandar Abbas 104 ICHD-2 Students Cross-sectional
Hashemilar 2004 Ardabil 631 ICHD-1 Students Cross-sectional
Ayatollahi 2005 Shiraz 538 ICHD-2 Teachers Cross-sectional
Bahrami 2006 Khoramabad 2213 Other questionnaire Students Cross-sectional
Shahraki 2006 Zahedan 1539 Other questionnaire Teachers Cross-sectional
Foroughi pour 2006 Mashhad 423 Other questionnaire Population-based Cross-sectional
Ayatollahi 2006 Shiraz 2226 ICHD-1 Students Cross-sectional
Sadreddini 2006 Tabriz 340 ICHD-2 Students Cross-sectional
Sedighi 2006 Kerman 4521 ICHD-1 Students Cross-sectional
Modara 2008 Ilam 309 ICHD-2 Students Cross-sectional
Ayatollahi 2009 Shiraz 1023 ICHD-2 Population-based Cross-sectional
Fallahzadeh 2011 Yazd 930 ICHD-1 Students Cross-sectional
Khazaie 2011 Birjand 723 ICHD-1 Students Cross-sectional
Shahraki 2011 Zahedan 210 ICHD-2 Students Cross-sectional
Zangeneh 2012 Isfahan 764 ICHD-2 Population-based Cross-sectional
Bahrami 2012 Khoramabad 1000 Other questionnaire Population-based Cross-sectional
Zarei 2012 Jahrom 1593 Other questionnaire Population-based Cross-sectional
Ghorbani 2013 Isfahan 480 ICHD-2 Students Cross-sectional
Yazdanparast 2013 BandarAbbas 350 ICHD-2 Students Cross-sectional
Shahbeigi 2013 Tehran 3655 ICHD-2 Population-based Cross-sectional
Tavasoli 2013 Tabriz 190 ICHD-2 Population-based Cross-sectional
Abdollahpour 2010 Boukan 857 ICHD-1 Students Cross-sectional
Seyed Saadat 2014 Rasht 541 ICHD-2 Population-based Cross-sectional
Ahmadpanah 2014 Hamadan 1000 ICHD-2 Population-based Cross-sectional
Rabiee 2015 Tehran 2076 ICHD-2 Population-based Cross-sectional
Table 2. Meta-Regression Analysis of Prevalence of Migraine in Iran
Coefficient Standard Error T P Confidence Interval 95%
Lower Upper
Publication year 0.0074331 0.0045972 1.62 0.118 -0.0019996 0.0168659
Sample size -0.0000157 0.0000191 -0.82 0.419 -0.0000549 0.0000235
Cons -14.76564 9.23323 -1.60 0.121 -33.71066 4.179387
view, using Egger’s test and funnel plot. The results showed that there existed publication bias among the studies (P =
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NOTE: Weights are from random effects analysis
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Figure 2. Forest Plot of Prevalence of Migraine in Iran Based on Diagnostic Criteria
0.000).
4. Discussion
The prevalence rate of Migraine obtained for an Iranian
population was obtained as 14%. This rate is higher than
that reported by Lipton et al. in US (43), Radtke and Han-
nelore in Germany (44), and Ertas et al. in Turkey (45), but
lower than that reported by Manandhar et al. in Nepal (46)
and Rao et al. in India (47). The articles obtained from
the subgroup were analyzed to evaluate the ratio of preva-
lence rate of migraine in the studied groups. In the cur-
rent study, the prevalence rate of migraine among medical
students was higher than that obtained by Ojini in Nige-
ria (48), and lower than that obtained by Bindu Menon
and Kinnera in India (49), and Kurt and Kaplan (50). The
difference in the prevalence rate of migraine in medical
students obtained from various studies can be justified
due to some reasons like diverse work methods or differ-
ences in the questionnaires used in studies. However, the
greater number of females in the studies in comparison
to the males could also be another reason for the preva-
lence of migraine in the students. Some stressful periods
like midterm or final exams could also be responsible for
the higher prevalence rate of migraine in the students.
Racial and economic differences, climatic conditions, feed-
ing habits and social situations may also be some fac-
tors which influenced the prevalence rate of migraine in
the students (51). In different studies, the prevalence rate
of migraine was investigated in medical students and ac-
Iran Red Crescent Med J. 2016; 18(10):e40061. 5
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Figure 3. Graphic Representation of Overall Distribution of Migraine in the Provinces in Iran
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Figure 4. Association Between Prevalence by Publication of Year and Sample Size
cording to the results; the students were more likely to
have migraines than any other non-medical students due
to the environmentally and educationally stressful condi-
tions (52, 53). Migraine in primary and high school stu-
dents is often associated with complaints of headaches,
and in many cases this issue prevents the students from at-
tending schools, resulting to disability in daily activities.
Iran is of a young population, and the identification of in-
dividuals who suffer from migraines can lead to the dis-
covery of treatment which can help to make the patients
an economically active workforce and more productive in
the society. At the secondary and high schools ages, daily
stresses faced by the students can lead to an increase in
the risk of migraine. Stressful events for students com-
mences from the beginning of school, and the expecta-
tions of parents from the students to attain the peak of
academic achievements is another reason which can cause
an increased incidence of migraine (54, 55). The inter-
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NOTE: Weights are from random effects analysis
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Figure 5. The Pooled Prevalence of Migraine in Iran Was Based on Sample Size
pretation of the prevalence with respect to different geo-
graphical areas in Iran showed high prevalence rate of mi-
graine in the South and West (40%). The southern regions
in Iran are geographically tropical and the air temperature
is very high. Daily activities and work-related stresses in
hot and harsh conditions could be the reason for the in-
creased prevalence of migraine in these areas. The Western
regions in Iran are associated with cold weather, and cities
in these areas often have large populations and lower eco-
nomic levels. These conditions prevent people from meet-
ing their financial needs. Hard physical activities and in-
dividual stresses could also be justifiable reasons for the
prevalence of migraine in these areas. A number of stud-
ies have noted the relationship between vitamin D levels
and the incidence of chronic pain (56). Some anecdotal
evidences indicated that vitamin D may have a role in the
incidence of headaches (57). The prevalence of migraine
is worldwide and in different geographic areas (3). Many
factors could be responsible for the differences in the ra-
tio of prevalence of migraine in several countries. Some of
these factors include cultures and also environmental and
genetic conditions (58). The results of this study suggest
that migraine is indeed influenced by climate, economic
index and cultural factors. It seems that job conditions can
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Figure 6. The Pooled Prevalence of Migraine in Iran Was Based on Diagnostic Criteria
either increase or decrease the prevalence of migraine in
patients. Of course, this issue requires additional study.
The results of the meta-regression indicated that there ex-
isted no significant relationship between the prevalence of
migraine and the year of publication and sample size of
the studies; however, Figure 4 shows a decreasing trend for
the prevalence of migraine in Iran; although this was not
found to be significant. These decreasing trends in coun-
tries might have resulted from factors like increased lev-
els of quality of life and the promotion of educational pro-
grams and diagnostic methods for migraine, to mention
a few. Notwithstanding, there may be unknown factors or
changes in the known contributory factors over time.
A comparison of the prevalence of migraine in differ-
ent regions of Iran indicated that it is widespread in the
western (21 %), southern (19 %), central and north (11 %), and
eastern (8 %) regions. It has been suggested that several
social, climatic conditions, economic, and cultural factors
may have effect on the prevalence of migraine. The differ-
ences in the prevalence of migraine between the various
regions in Iran are therefore not surprising, given that the
Iranian population exhibits cultural diversity and differ-
ent economic index. It seems that the results of this study
indicate that the living conditions can also have a great
impact on the higher prevalence of migraine in the differ-
ent groups of the society, such students. This agrees with
the previous findings that migraine prevalence increases
rapidly in studies regarding age.
One of the major advantages of this study is the huge
sample size which is a valuable study in the field of evalu-
ating the prevalence rate of migraine in Iran. Over the past
years, in Iran, the prevalence of migraine in a population
based on various studies in different provinces has been
evaluated using a variety of methods performed by ques-
tionnaires and face to face interviews. The incongruity
among 30 studies was analyzed. Some limitations of the
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NOTE: Weights are from random effects analysis
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Figure 7. The Pooled Prevalence of Migraine in Iran Was Based on Groups of Participants
study are: in the present study, the methods of conduct-
ing the 30 studies entered into the analysis contained large
variety, and the significant heterogeneity was identified
among studies. This issue had effect on the accuracy of
the results. Lack of consistency in the diagnostic criteria in
some studies regarding the diagnosis of migraine was one
of the important reasons for heterogeneity among studies.
Also, in some provinces of Iran, there existed no previous
studies on the prevalence of migraine. There was no appro-
priate data according to gender and age in some studies.
Under such conditions, the results of this study should be
interpreted with caution.
In conclusion, migraine in Iran has an estimated preva-
lence of 14%. The study showed that the prevalence of mi-
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NOTE: Weights are from random effects analysis
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Figure 8. The Pooled Prevalence of Migraine in Iran Was Based on Geographical Region
NOTE: Weights are from random effects analysis
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Figure 9. The Pooled Prevalence of Migraine in Iran Was Based on Quality of Studies
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Figure 11. Funnel Plot and Egger Test to Assess Publication Bias
graine is high in Iran. Considering the impacts of migraine
on economic productivity of any country, it seems neces-
sary to train people for the early detection and obtaining of
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effective treatment of migraine. However, more studies are
required to assess the prevalence of migraine in the popu-
lation of Iran.
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